Morgan Stanley Downgrades Inspire Medical Systems to Equal-Weight, Raises Price Target to $130

Benzinga · 4d ago
Morgan Stanley analyst Kallum Titchmarsh downgrades Inspire Medical Systems (NYSE:INSP) from Overweight to Equal-Weight and raises the price target from $105 to $130.